Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.
Wheeler Bio has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in March 2025.
Wheeler Bio's investors include Alloy Therapeutics, Germin8 Ventures, Charles River Laboratories International, Echo Investment Capital, ATUM.
Wheeler Bio is headquartered in Oklahoma City, United States.
Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.
Wheeler Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Wheeler Bio — Funding & Investors." VCBacked, March 20, 2025, https://www.vcbacked.co/company/wheeler-bio. Accessed August 1, 2026.
VCBacked. (2025). Wheeler Bio — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/wheeler-bio
{{cite web |title=Wheeler Bio — Funding & Investors |url=https://www.vcbacked.co/company/wheeler-bio |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated